Skip to main content
James McKiernan, MD, Urology, New York, NY, New York-Presbyterian Hospital

JamesMMcKiernanMD

Urology New York, NY

Surgical Oncology

John K. Lattimer Professor and Chair Department of Urology Columbia University College of P&S Urologist-In-Chief NYPH

Overview of Dr. McKiernan

Dr. James McKiernan is an urologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center, and NewYork-Presbyterian/Allen Hospital. He received his medical degree from Columbia University Vagelos College of Physicians and Surgeons and has been in practice 24 years. He is one of 185 doctors at New York-Presbyterian Hospital and one of 7 doctors at NewYork-Presbyterian/Allen Hospital who specialize in Urology. He has more than 100 publications and over 500 citings.

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Urology, 1995 - 1999
  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Residency, Surgery, 1993 - 1995
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 1993
  • Johns Hopkins University
    Johns Hopkins UniversityB.A., Biology, 1989

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • NJ State Medical License
    NJ State Medical License 2021 - 2025
  • NY State Medical License
    NY State Medical License 1996 - 2025
  • American Board of Urology Urology

Awards, Honors, & Recognition

  • Top Doctors: New York Metro Area Castle Connolly, 2007-2014
  • New York Magazine: Top Doctors Castle Connolly, 2012, 2014
  • Humanism in Medicine Award Arnold P. Gold Foundation, 2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Impact of synchronous metastasis distribution on cancer-specific survival in renal cell carcinoma after radical nephrectomy with tumor thrombectomy  
    Tilki D, Hu B, Nguyen HG, Dall'Era MA, Bertini R, Carballido JA, Chandrasekar T, Chromecki T, Ciancio G, Daneshmand S, Gontero P, Gonzalez J, Haferkamp A, Hohenfellner..., Urol, 7/22/2014
  • Cost-effectiveness of neoadjuvant chemotherapy before radical cystectomy for muscle-invasive bladder cancer  
    Stevenson SM, Danzig MR, Ghandour RA, Deibert CM, Joel Decastro G, Benson MC, McKiernan JM, Urol Oncol, 7/3/2014
  • Phase II Trial of Intravesical Nanoparticle Albumin-Bound (nab-) Paclitaxel for the Treatment of Non-Muscle Invasive Urothelial Carcinoma of the Bladder after BCG Trea...  
    McKiernan JM, Holder DD, Ghandour RA, Barlow LJ, Ahn JJ, Kates M, Badalato GM, Roychoudhury A, Decastro GJ, Benson MC, J Urol, 7/1/2014
  • Join now to see all

Books/Book Chapters

Authored Content

  • Is Imperative Partial Nephrectomy Feasible for Kidney Cancer with Venous Thrombus Involvement? Outcomes of 42 Cases and Matched Pair Analysis with a Large Radical Nephrectomy CohortMay 2018
  • Is Imperative Partial Nephrectomy Feasible for Kidney Cancer with Venous Thrombus Involvement? Outcomes of 42 Cases and Matched Pair Analysis with a Large Radical Nephrectomy CohortMay 2018
  • Is Imperative Partial Nephrectomy Feasible for Kidney Cancer with Venous Thrombus Involvement? Outcomes of 42 Cases and Matched Pair Analysis with a Large Radical Nephrectomy CohortMay 2018

Press Mentions

  • New Treatment Options Emerging for Patients with Refractory NMIBC
    New Treatment Options Emerging for Patients with Refractory NMIBCMay 13th, 2022
  • Bio-Techne Announces Publication of ExoDx Prostate Test Study in Patients with Prior Negative Prostate Biopsy
    Bio-Techne Announces Publication of ExoDx Prostate Test Study in Patients with Prior Negative Prostate BiopsySeptember 23rd, 2020
  • miR Scientific Announces Validation of Its Urine Based, Non-Invasive Prostate Cancer Test Published in the Journal of Urology
    miR Scientific Announces Validation of Its Urine Based, Non-Invasive Prostate Cancer Test Published in the Journal of UrologyAugust 10th, 2020
  • Join now to see all

Hospital Affiliations